Christian Pfrepper/ResearchGate
Oct 3, 2025, 12:40
Christian Pfrepper and Team’s Letter on Emicizumab Plasma Concentration Measurment in EDTA plasma
RPTH Journal shared on LinkedIn:
”It’s mail day here at RPTH Journal
Check out this Research Letter from Christian Pfrepper and team showing that Emicizumab plasma concentration can be measured in EDTA plasma without relevant influence of residual FVIII.”
Read the full article here.
Article: Assessment of emicizumab levels in EDTA plasma
Authors: Christian Pfrepper, Annelie Siegemund, Tristan Klöter, Hagen Bönigk, Sirak Petros, Thomas Siegemund
Stay updated on all scientific advances in the field of hemophilia with Hemostasis Today.
-
Feb 25, 2026, 09:14Nominations are Open for 2027 Committee and Leadership Positions – ASH
-
Feb 25, 2026, 09:08Bastu Odoka: Closing the Gap on Anti-D Prophylaxis in Maternal Care
-
Feb 25, 2026, 08:53Eiman Alzaabi: Sharing Rare Observations and Challenging Assumptions in Transfusion Medicine
-
Feb 25, 2026, 08:40Matthew Flick։ A Great Gordon Research Conference on Plasminogen Activation and Extracellular Proteolysis
-
Feb 24, 2026, 16:18Salmaan Dalvi: Mapping Rare Diseases Across East and Central Africa
-
Feb 24, 2026, 16:16Wolfgang Miesbach: Game‑Changing Data on Intensive FVIII Replacement in Haemophilia A with Hypertrophic Synovium
-
Feb 24, 2026, 16:01Is It Safe to Briefly Stop Anticoagulation After VTE? – RPTH Journal
-
Feb 24, 2026, 15:58Anastasia Conti: Honored to Receive the Roche Foundation Grant for Independent Research in Onco-Hematology
-
Feb 24, 2026, 15:55Courtney Lawrence: Targeted Donor Screening Reduces Transfusion-Transmitted Babesia Cases